[go: up one dir, main page]

NO953002L - Anvendelse av eliprodil og enantiomerer derav for fremstilling av medisinske preparater - Google Patents

Anvendelse av eliprodil og enantiomerer derav for fremstilling av medisinske preparater

Info

Publication number
NO953002L
NO953002L NO953002A NO953002A NO953002L NO 953002 L NO953002 L NO 953002L NO 953002 A NO953002 A NO 953002A NO 953002 A NO953002 A NO 953002A NO 953002 L NO953002 L NO 953002L
Authority
NO
Norway
Prior art keywords
eliprodil
enantiomers
preparation
medical preparations
preparations
Prior art date
Application number
NO953002A
Other languages
English (en)
Other versions
NO953002D0 (no
NO307285B1 (no
Inventor
Delphine Lekieffre
Jesus Benavides
Bernard Scatton
Pascal George
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO953002D0 publication Critical patent/NO953002D0/no
Publication of NO953002L publication Critical patent/NO953002L/no
Publication of NO307285B1 publication Critical patent/NO307285B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO953002A 1994-07-29 1995-07-28 Anvendelse av eliprodil og enantiomerer derav for fremstilling av medisinske preparater NO307285B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9409409A FR2722987B1 (fr) 1994-07-29 1994-07-29 Utilisation de l'eliprodil et de ses enantiomeres pour la preparation de medicaments utiles dans la prevention des neuropathiesinduites par des agentsanticancereux

Publications (3)

Publication Number Publication Date
NO953002D0 NO953002D0 (no) 1995-07-28
NO953002L true NO953002L (no) 1996-01-30
NO307285B1 NO307285B1 (no) 2000-03-13

Family

ID=9465880

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953002A NO307285B1 (no) 1994-07-29 1995-07-28 Anvendelse av eliprodil og enantiomerer derav for fremstilling av medisinske preparater

Country Status (8)

Country Link
US (1) US5652248A (no)
EP (1) EP0694303A1 (no)
JP (1) JPH0840903A (no)
KR (1) KR960003717A (no)
CA (1) CA2154907A1 (no)
FI (1) FI953621A7 (no)
FR (1) FR2722987B1 (no)
NO (1) NO307285B1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5778098A (en) * 1997-07-18 1999-02-10 New Era Biotech Limited Therapeutic substance for use in the treatment of aids and immuno-allergical diseases
US8710095B2 (en) * 2002-04-30 2014-04-29 Bionumerik Pharmaceuticals, Inc. Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
JP2006503069A (ja) * 2002-09-25 2006-01-26 ジョージア テック リサーチ コーポレイション 慢性神経疾患におけるケトアミド阻害剤
JP4208036B1 (ja) * 2007-04-26 2009-01-14 日本新薬株式会社 抗癌剤投与に伴う末梢神経障害抑制用医薬組成物
KR101689513B1 (ko) * 2015-10-06 2016-12-27 한국 한의학 연구원 백부근 추출물을 유효성분으로 함유하는 말초신경병증 예방, 개선 또는 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent

Also Published As

Publication number Publication date
NO953002D0 (no) 1995-07-28
NO307285B1 (no) 2000-03-13
FI953621L (fi) 1996-01-30
FR2722987B1 (fr) 1997-05-16
CA2154907A1 (en) 1996-01-30
FI953621A7 (fi) 1996-01-30
FI953621A0 (fi) 1995-07-28
US5652248A (en) 1997-07-29
FR2722987A1 (fr) 1996-02-02
KR960003717A (ko) 1996-02-23
JPH0840903A (ja) 1996-02-13
EP0694303A1 (fr) 1996-01-31

Similar Documents

Publication Publication Date Title
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
NO971015L (no) Forbindelser og metoder for behandling av cancer
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
DE69815833D1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
NO885453D0 (no) Silisiumpulver og fremgangsmaate for fremstilling av silisiumpulver.
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
FI972245A7 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
FI965204A0 (fi) Bromelaiinin lääkekäyttö
NO307930B1 (no) Benzo[f]kinolinoner, farmasøytisk formulering omfattende samme og anvendelse av samme for fremstilling av formulering for behandling
FI951060L (fi) Formulaatioita ja hoitomenetelmiä
NO940027L (no) Fremgangsmaate for fremstilling av derivater av B-fenylisorerin og derivatenes anvendelse
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
NO955258D0 (no) Medisinsk anvendelse av enzymer
NO994505D0 (no) Forbedret fremgangsmÕte for fremstilling av tiazolidindioner og nye tiazolidindioner
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
NO307285B1 (no) Anvendelse av eliprodil og enantiomerer derav for fremstilling av medisinske preparater
NO932129D0 (no) Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater
NO953003D0 (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
NO921086L (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
NO905543D0 (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
NO985572D0 (no) Substituerte amidinobenzenderivater og medisinske preparater derav
NO962782L (no) Farmasöytiske formuleringer omfattende polytiourea, og metode for anvendelse derav

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2002